Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:07 PM
Ignite Modification Date:
2025-12-24 @ 4:07 PM
NCT ID:
NCT00413166
Eligibility Criteria:
Inclusion Criteria:
1. A diagnosis of APL based on the presence of the PML-RAR alpha fusion gene by cytogenetics, PCR, or POD test.
2. Provision of written informed consent.
3. Patients in whom therapy for APL was initiated on an emergent basis are eligible
Exclusion Criteria:
1. First trimester of pregnancy (ATRA is teratogenic)
2. Corrected QT (QTC) interval must not be greater than 480 milliseconds.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00413166
Study Brief:
Protocol Section:
NCT00413166